Patents Assigned to Roche Diabetes Care, Inc.
  • Publication number: 20240029857
    Abstract: A method for generating activity recommendations in a diabetes treatment plan includes receiving physiological data, preferences, and suggested activities for a person with diabetes (PwD), generating physiological profiles for the PwD, providing the physiological profiles to a virtual physiological model, receiving projections from a virtual physiological model, generating weighted values based on the suggested activities and preference data, each weighted value corresponding to a likelihood of the PwD adhering to a suggested activity, ranking each activity based on the estimated change in the physiological characteristic of a projection associated with the activity relative to a baseline physiological projection and scaled by the weighted value corresponding to each activity, and generating an output including a predetermined number of suggested activities ordered based on the ranking of activities that provide a greatest change in the physiological characteristic given the likelihood of the PwD adhering to
    Type: Application
    Filed: October 3, 2023
    Publication date: January 25, 2024
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Jennifer Fisher, Paul Galley, Mark Mears
  • Patent number: 11877869
    Abstract: The disclosure relates to a method and a system for determining a carbohydrate intake event from glucose monitoring data indicative of a glucose level in a system having a data processing device provided with one or more processors.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: January 23, 2024
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Andreas Reichel, Tobias Wiesner, Bernd Steiger
  • Patent number: 11876894
    Abstract: A system and method for controlling recall of a product in a computer network. A pair of product keys can be assigned to the product including a private product key and a public product key. A pair of product recall keys can be assigned to a product recall, including a private product recall key and a public product recall key. A data processing device assigned to a manufacturer in the computer network can be configured to print a matrix code on the product and generate a recall transaction assigned to the product indicating a recall request for the product. The data processing device can sign the recall transaction with the private product recall key and a private manufacturer key. A second data processing device is configured to scan the printed matrix code on the product and provide the public product recall key by decrypting the printed matrix code.
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: January 16, 2024
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Christoph John
  • Patent number: 11864888
    Abstract: A method is provided for constructing a structured test having user-defined adherence criteria. The method includes: presenting a patient with a plurality of contextual criterion for a structured test; receiving selection of one or more contextual criterion from the plurality of contextual criterion; and constructing a structured test that includes the contextual criterion selected by the patient. During administration of the structured test, each of the contextual criteria selected by the patient is evaluated. Sample data acquired during the structured test is reported as compliant when each of the context criterion selected by the patient was met during the administration of the structured test or tagged as non-compliant when at least one contextual criterion was not met during the administration of the structured test.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: January 9, 2024
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Steven A. Bousamra
  • Patent number: 11864887
    Abstract: In diabetes management applications, recent glucose measurement values may be clinically useful for acute diagnosis and for the calculation of a corrective therapy. However, the physiological significance of these measurements can lessen with time, which can lead to their becoming less relevant for calculating an effective therapy. A technique is presented for emphasizing analyte values in a diabetes management application during a therapeutic window. In this way, a user is notified that the glucose measurement value is the most current measurement and remains usable for therapy applications, such as an insulin bolus calculation.
    Type: Grant
    Filed: October 20, 2017
    Date of Patent: January 9, 2024
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Eric S. Carlsgaard, Nils Babion
  • Patent number: 11851685
    Abstract: Described herein are reagent compositions for detecting and/or measuring analytes in a test sample. In one embodiment, reagent compositions are described for detecting and/or measuring glucose in a sample.
    Type: Grant
    Filed: November 8, 2021
    Date of Patent: December 26, 2023
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Nathan Allen Carrington, Stacy Hunt Duvall, Leon Scott Van Dyke
  • Patent number: 11835515
    Abstract: A method of evaluating suitability of lighting conditions for detecting an analyte in a sample using a mobile device camera. A test strip is provided for detecting the analyte. A first image of the test strip is captured while an illumination source of the mobile device is turned off and a second image of the test strip is captured while the illumination source is turned on. A sample is applied to the test strip and the first and second images are compared to thereby determine the difference in lighting conditions between the first image and the second image. The comparison is used to derive information on suitability of the lighting conditions for analyte detection. The lighting conditions are indicated as suitable when a predetermined threshold amount of light intensity used for illumination of the test strip originates from the illumination source.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: December 5, 2023
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Max Berg, Fredrik Hailer, Timo Klein, Bernd Limburg, Christian Melchinger, Volker Tuerck
  • Patent number: 11837078
    Abstract: An ambulatory medical device for attachment to a person's body includes a housing having a wall and a vibrator coupler. A convex outer surface of the vibrator coupler projects from the wall towards the outside of the housing. The vibrator coupler is coupled to the wall via a connector arranged along the circumference of the vibrator coupler. A vibrator mechanically vibrates upon activation. The vibrator is arranged at least partially inside a volume defined by the vibrator coupler and is mounted to the vibrator coupler. A skin attachment device is also disclosed. It has a substantially planar body having a skin attachment side and an opposing medical device mounting side. The skin attachment side includes a skin attachment structure for releasably attaching the skin attachment device to a person's skin and the medical device mounting side includes a medical device mount for releasably engaging with the ambulatory medical device.
    Type: Grant
    Filed: October 1, 2021
    Date of Patent: December 5, 2023
    Assignee: Roche Diabetes Care, Inc.
    Inventors: Steffan Wuerzburger, Hans List
  • Patent number: 11835511
    Abstract: A resealable container including a housing, a lid coupled to the housing, and a basket received within the housing and including side walls defining an interior space, and a retainer extending over at least a portion of the interior space and configured to support at least one test element in at least one of a side-to-side direction and a front-to-back direction within the basket.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: December 5, 2023
    Assignee: ROCHE DIABETES CARE, INC.
    Inventors: Isaac A. Norman, Frank A. Chan
  • Publication number: 20230380733
    Abstract: A medical device for detecting at least one analyte in a body fluid is disclosed.
    Type: Application
    Filed: August 2, 2023
    Publication date: November 30, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Helmut Walter
  • Publication number: 20230384255
    Abstract: The present invention relates to a method for the preparation of a working electrode, the method comprising application of a sensing material in several steps. Further, the present invention relates to an analyte sensor comprising the working electrode as well as to the use of the analyte sensor for detecting at least one analyte in a sample.
    Type: Application
    Filed: November 22, 2021
    Publication date: November 30, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Arnfried Guenther, Alexander Steck
  • Publication number: 20230371857
    Abstract: A medical device for detecting at least one analyte in a body fluid is disclosed.
    Type: Application
    Filed: August 2, 2023
    Publication date: November 23, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Helmut Walter
  • Publication number: 20230371860
    Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and-a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 23, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Helmut Walter
  • Publication number: 20230371859
    Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and—a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 23, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Helmut Walter
  • Publication number: 20230371856
    Abstract: A medical device for detecting at least one analyte in a body fluid is disclosed.
    Type: Application
    Filed: August 1, 2023
    Publication date: November 23, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Helmut Walter
  • Publication number: 20230371861
    Abstract: A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises: an analyte sensor having an insertable portion; an insertion cannula receiving the insertable portion of the analyte sensor; an electronics unit connected with the analyte sensor; and a housing comprising an electronics compartment receiving the electronics unit and a sensor compartment receiving the analyte sensor, the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor, the sealed compartment comprising detachable upper and lower caps, the lower cap configured for detachment before insertion, the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula, wherein the electronics compartment at least partially surrounds the sensor compartment.
    Type: Application
    Filed: August 1, 2023
    Publication date: November 23, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Helmut Walter
  • Publication number: 20230364331
    Abstract: An insertion system comprises a medical device and an insertion device for inserting the medical device into a body tissue of a user, the insertion device comprising: an insertion component-configured for inserting the medical device into the body tissue; an insertion component retractor; a cap; a guide sleeve and an insertion sleeve guided therein; a locking sleeve in the insertion sleeve; and an elastic member positioned between the locking sleeve and the insertion component retractor; wherein, for inserting the medical device, the cap, the insertion component retractor, the locking sleeve and the insertion sleeve are movable relative to the guide sleeve from a distal position to a proximal position, wherein the insertion device is separable from the medical device, wherein the insertion system is separation of the insertion device from the medical device releasing a movement of the locking sleeve from its proximal position to a further proximal position.
    Type: Application
    Filed: July 26, 2023
    Publication date: November 16, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Hans List, Bruno Thoes
  • Publication number: 20230355875
    Abstract: Medical device efficiency detection methods and systems including a photoplethysmography (PPG) sensor device, a processor, a memory, and machine readable instructions that may cause the system to receive a notification at the PPG device from the medical device upon delivery of the therapy treatment, use the PPG device to search for a signal response of the user based on the notification within a period of time to generate a response signal indicative of therapy treatment delivery, and transmit an alert when the response signal is not generated in the period of time indicative of a failure to detect sufficient therapy treatment delivery. The instructions may cause the system to transmit an alert when signal measurements from the PPG device of an infusion site are not within a sufficient signal range to indicate the infusion site is insufficient for delivery of the therapy treatment by the medical device.
    Type: Application
    Filed: July 18, 2023
    Publication date: November 9, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventors: Timothy N Aykroyd, Alexander Licht, Stephanie Ann Wooten
  • Publication number: 20230351867
    Abstract: An alert is used to inform a user that their blood glucose level has dropped below a threshold (e.g., the user is hypoglycemic) or has increased above a threshold (e.g., the user is hyperglycemic). There is a hierarchy of alerts from lowest priority to highest priority. The alert is communicated by a user device (e.g., a mobile device), which is, for example, a smartphone, smart watch, home automation device, or the like. The alert is modified in order to increase the likelihood that the user receives or acknowledges the alert within a minimal amount of time. An intensity level (e.g., a volume) of an alert is modified based on, for example, whether the user has acknowledged a previous alert. A modality or a sensory channel of an alert is changed if an initial alert does fails to elicit a response from the user.
    Type: Application
    Filed: July 11, 2023
    Publication date: November 2, 2023
    Applicant: Roche Diabetes Care, Inc.
    Inventor: Mark Gilmore Mears
  • Patent number: 11793934
    Abstract: Disclosed is a medical system having a cartridge and an inserter. The cartridge includes a housing having an interior volume with a first guide within the interior volume. A cradle is disposed within the interior volume and is configured for mounting a medical appliance. The cradle includes a subcutaneous element and an insertion needle. The insertion needle is configured for being actuated to insert the subcutaneous element into a subject. The inserter includes a second guide configured to mate with the housing of the cartridge, and the first guide and second guide are configured to cooperate to guide the inserter into the interior volume along a guiding path defined by the first guide. The inserter is configured to removably attach to the cradle when guided into the interior volume. An insertion assembly is provided for actuating the insertion needle to insert the subcutaneous element into the subject.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: October 24, 2023
    Assignee: Roche Diabetes Care, Inc.
    Inventor: Frank Deck